Number of shares and voting rights of Innate Pharma as at August 1, 2020

NEXT STORY
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
PREV STORY
Growth Opportunities for IoT-enabled medical devices for Infectious disease management
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Phase 2 Study of Single-agent Glembatumumab Vedotin in Patients with Checkpoint-Refractory Metastatic Melanoma Meets Primary Overall Response Endpoint and Demonstrates Clinically Meaningful Duration of Response

HAMPTON, N.J., Oct. 09, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today presented ...

author_avatar
NASDAQ Market News

Sales of darolutamide started in the USA – Orion receives EUR 45 million milestone

author_avatar
NASDAQ Market News

Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019

author_avatar
NASDAQ Market News